Myeloid Therapeutics, Inc. announced that it has expanded its manufacturing capabilities with the appointments of Jerome Chal, Ph.D., as Vice President, Process Development, and Eric Chapdelaine as Vice President, CMC Operations.
August 23, 2022
· 4 min read